📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. (2016)

First Author: Raftopoulos R

Attributed to: MICA: Exploring GABAAalpha2,3 receptor signalling as novel therapy for focal dystonias and peripheral neuropathies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(16)00004-1

PubMed Identifier: 26822749

Publication URI: http://europepmc.org/abstract/MED/26822749

Type: Journal Article/Review

Volume: 15

Parent Publication: The Lancet. Neurology

Issue: 3

ISSN: 1474-4422